Cargando…

3. Certolizumab pegol for BehÇet's flare in pregnancy: a case report

Detalles Bibliográficos
Autores principales:	Piper, Madeleine, Goodwin, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	B. ORAL PRESENTATIONS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652573/ http://dx.doi.org/10.1093/rap/rkx012.002

Ejemplares similares

5. Certolizumab Pegol for RA in pregnancy
por: Thorne, Iona, et al.
Publicado: (2017)

20. Neurovascular BehÇet’s syndrome: lessons in management from a centre of excellence
por: Dolan, Lauren A, et al.
Publicado: (2018)

O16 A diagnosis of BehÇet’s Disease with secondary antiphospholipid syndrome
por: Jones, Alexandra, et al.
Publicado: (2021)

40. Rivaroxaban for treatment of vascular BehÇet's disease
por: Musa, Reem, et al.
Publicado: (2018)

88. Fibromyalgia in BehÇet's disease: any role for helicobacter screen and eradication?
por: Bashir, Yasmin, et al.
Publicado: (2018)

50. Vascular BehÇet’s disease in a 20-year-old man presenting with an abdominal aortic aneurysm
por: Levasseur, Kirsty, et al.
Publicado: (2019)

4. A challenging case of refractory BehÇet's disease in an adolescent with sight threatening uveitis
por: Cooper, Gisella, et al.
Publicado: (2018)

87. Cardiac presentation of BehÇet's disease: the impact of HLA-B51 positivity in early diagnosis
por: Adamjee, Qainat R, et al.
Publicado: (2018)

Reverse signalling of membrane TNF in human natural killer cells: a comparison of the effect of certolizumab pegol and other anti-TNF agents
por: Fossati, Gianluca, et al.
Publicado: (2011)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
por: Henry, Alistair I, et al.
Publicado: (2011)

6. A case of antisynthetase syndrome in pregnancy
por: Green, Lauren, et al.
Publicado: (2017)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
por: Baysal, Mehmet, et al.
Publicado: (2018)

4. A case of AOSD with acute hepatitis during pregnancy
por: Hadavi, Shahryar, et al.
Publicado: (2017)

2. Severe autoimmune neutropenia in Lupus and its management in pregnancy
por: Raghunath, Radhika, et al.
Publicado: (2017)

1. Early scleroderma overlap syndrome (pulmonary hypertension, ILD, polymyositis and inflammatory arthritis) and an unplanned pregnancy
por: Thorne, Iona, et al.
Publicado: (2017)

Active axial spondyloarthritis: potential role of certolizumab pegol
por: Ranatunga, Sriya, et al.
Publicado: (2014)

Patient Satisfaction with CIMZIA(®) (Certolizumab Pegol) AutoClicks(®) in the UK
por: Bailey, Kathryn, et al.
Publicado: (2020)

Impact of Certolizumab Pegol on Patient‐Reported Outcomes in Patients With Axial Spondyloarthritis
por: Sieper, J., et al.
Publicado: (2015)

Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
por: Barnes, Theresa, et al.
Publicado: (2007)

New biologics in the management of Crohn’s disease: focus on certolizumab pegol
por: Colombo, Elisabetta, et al.
Publicado: (2009)

Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn’s Disease
por: Blonski, Wojciech, et al.
Publicado: (2012)

Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease
por: Wade, Janet R., et al.
Publicado: (2015)

Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis
por: Sharon, Yael, et al.
Publicado: (2020)

Certolizumab pegol treatment for leg ulcers due to rheumatoid vasculitis
por: Meling, Maureen Tania, et al.
Publicado: (2021)

Renal sarcoidosis associated with certolizumab pegol treatment for psoriatic arthritis
por: Hum, Ryan M, et al.
Publicado: (2022)

P42 Primary Sjogren’s Syndrome (pSS) in a seronegative adolescent female with family history of BehÇet’s disease: A challenging disease to diagnose Case-based discussion
por: Gharaibeh, Aseel, et al.
Publicado: (2022)

The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW
por: van der Horst-Bruinsma, Irene, et al.
Publicado: (2020)

Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis
por: Furst, D E, et al.
Publicado: (2015)

Factors associated with successful discontinuation of certolizumab pegol in early rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2020)

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis
por: Hannech, Emna, et al.
Publicado: (2021)

Successful treatment of dissecting cellulitis with certolizumab pegol in a pregnant patient
por: Almuhanna, Nouf, et al.
Publicado: (2023)

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database
por: Clowse, Megan E. B., et al.
Publicado: (2018)

Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol
por: Clowse, Megan, et al.
Publicado: (2022)

Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays
por: Fossati, G, et al.
Publicado: (2010)

14. A challenging case of Fibromyalgia and Post-Traumatic Stress Disorder
por: Ming, Caroline, et al.
Publicado: (2017)

11. Autotomy wish in complex regional pain syndrome: an integral part of the condition?
por: Shaikh, Maliha
Publicado: (2017)

9. Psoriatic Arthritis: A long and winding road
por: King, Alice, et al.
Publicado: (2017)

16. A Challenging Case of Gout
por: Ahmed Syed, Sami, et al.
Publicado: (2017)

10. Reactivation of hepatitis B virus in a patient with psoriatic arthritis treated with methotrexate
por: Mudawi, Tareg, et al.
Publicado: (2017)

12. Eosinophilic fasciitis-case presentation and review of literature
por: Khalid, Sameena, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pf1c5dd3stspjq5eckd1nskfmu